-
Mar 10, 2021, 10:10 AM
by
Full story
-
Mar 10, 2021, 10:10 AM
by
SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.
Full story
-
Mar 10, 2021, 10:10 AM
by
Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.
Full story
-
Mar 10, 2021, 10:10 AM
by
VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
Full story
-
Mar 10, 2021, 10:10 AM
by
Full story
-
Mar 10, 2021, 10:05 AM
by
Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
Full story
-
Mar 9, 2021, 01:00 AM
by
User Not Found
Bio-IT World | The foundation of a data commons is the data dictionary—the map or model populated with all of the data within an organization and the relationships between them. The hardest part of FAIR is the “I”—interoperability, says Bill Van Etten, senior scientific consultant at BioTeam. The data dictionary is what brings you from FAR to FAIR.
Full story
-
Mar 8, 2021, 01:00 AM
by
User Not Found
Bio-IT World | New products and company updates from around Bio-IT including Seven Bridges’ partnership with Pfizer, Illumina’s Russian approval, new methylation detection platform from Twist, and more.
Full story
-
Mar 5, 2021, 01:00 AM
by
User Not Found
Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.
Full story
-
Mar 4, 2021, 01:00 AM
by
User Not Found
Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.
Full story
-
Mar 3, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Neville Sanjana from the New York Genome Center and NYU turned his attention to COVID-19 early in the pandemic. For several years, his lab has focused on using CRISPR to identify which regions of the genome drive disease. Last year, he applied that expertise to using genome-wide CRISPR screens to look for COVID-19 risk factors.
Full story
-
Mar 2, 2021, 14:37 PM
by
User Not Found
Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
Full story
-
Mar 1, 2021, 16:51 PM
by
User Not Found
Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
Full story
-
Mar 1, 2021, 09:38 AM
by
• Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network.
• Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency.
• Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse.
• Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
Full story
-
Mar 1, 2021, 09:38 AM
by
John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
Full story